DNA vaccines for cancer treatment
Kaneda, Y.; Hoon, D.S.
Idrugs the Investigational Drugs Journal 4(3): 301-311
2001
ISSN/ISBN: 1369-7056 PMID: 16025391 Document Number: 538677
Document emailed within 1 workday
Related Documents
Petricciani, J. 2004: Are cancer vaccines really the same as infectious disease vaccines? Developments in Biologicals 116: 13-18Toh, U.; Saku, S.; Okabe, M.; Iwakuma, N.; Kimitsuki, Y.; Akashi, M.; Ogo, E.; Yamada, A.; Shichijo, S.; Itoh, K.; Akagi, Y. 2016: Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(10): 1249-1251
Lugosi, L. 1977: Control of viability, thermostability and residual virulene of BCG vaccines. Multiple comparison of laboratory data to select products for immunostimulation in the treatment of cancer Developments in Biological Standardization 38: 45-50
Minev, B.R.; Guo, F.; Gueorguieva, I.; Kaiser, H.E. 2002: Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects In Vivo 16(6): 405-415
Emens, L.A.; Machiels, J.P.; Reilly, R.T.; Jaffee, E.M. 2001: Chemotherapy: friend or foe to cancer vaccines? Current Opinion in Molecular Therapeutics 3(1): 77-84
Zhu, D.; Stevenson, F.K. 2002: DNA gene fusion vaccines against cancer Current Opinion in Molecular Therapeutics 4(1): 41-48
Merika, E.; Saif, M.W.; Katz, A.; Syrigos, K.; Syrigos, C.; Morse, M. 2010: Review. Colon cancer vaccines: an update In Vivo 24(5): 607-628
Paul, S.ép.; Acres, B.; Limacher, J.-M.; Bonnefoy, J.-Y. 2007: Cancer vaccines: challenges and outlook in the field Idrugs: the Investigational Drugs Journal 10(5): 324-328
Mitchell, M.S. 2002: Cancer vaccines, a critical review--Part Ii Current Opinion in Investigational Drugs 3(1): 150-158
Hwang, L.C.; Fein, S.; Levitsky, H.; Nelson, W.G. 1999: Prostate cancer vaccines: current status Seminars in Oncology 26(2): 192-201
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Steller, M.A. 2002: Update on human papillomavirus vaccines for cervical cancer Current Opinion in Investigational Drugs 3(1): 37-47
Schlom, J.; Tsang, K.Y.; Kantor, J.A.; Abrams, S.I.; Zaremba, S.; Greiner, J.; Hodge, J.W. 1999: Strategies in the development of recombinant vaccines for colon cancer Seminars in Oncology 26(6): 672-682
Gariglio, P.; Benitez-Bribiesca, L.; Berumen, J.; Alcocer, J.M.; Tamez, R.; Madrid, V. 1998: Therapeutic uterine-cervix cancer vaccines in humans Archives of Medical Research 29(4): 279-284
Dalgleish, A. 2007: Overcoming technical challenges in the development of cancer vaccines Idrugs: the Investigational Drugs Journal 10(7): 463-467
Altinbas, S.K.; Tapisiz, O.L. 2012: Human papillomavirus, vaccines, and protection from cervical cancer Saudi Medical Journal 33(12): 1270-1277
Humphrey, L.J.; Murray, D.R.; Boehm, O.R. 1971: Effect of tumor vaccines in immunizing patients with cancer Surgery Gynecology and Obstetrics 132(3): 437-442
Wegmann, A.; Glück, R.; Just, M.; Mischler, R.; Paroz, P.; Germanier, R. 1986: Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines Developments in Biological Standardization 65: 69-74
Prince, A.M.; Vnek, J. 1982: Hepatitis B vaccines. An evaluation of human plasma extracted vaccines Fortschritte der Medizin 100(40): 1839-1843
Clements, C.J.; Abdool-Karim, Q.; Chang, M.-L.; Nkowane, B.; Esparza, J. 2004: Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine 22(21-22): 2822-2826